Trintellix Drug Class and Starting Dose
Trintellix (vortioxetine) is a multimodal antidepressant classified as a serotonin modulator and stimulator (SMS), and the recommended starting dose is 10 mg once daily taken orally without regard to meals 1.
Drug Classification
Vortioxetine has a unique multimodal mechanism of action that distinguishes it from traditional antidepressants 2, 3. It functions through:
- Serotonin transporter (SERT) inhibition
- 5-HT1A receptor agonism
- 5-HT3 and 5-HT7 receptor antagonism
- 5-HT1B receptor partial agonism
This multimodal profile affects multiple neurotransmitter systems including serotonin, glutamate, GABA, norepinephrine, acetylcholine, and dopamine 4. While it shares some properties with SSRIs and SNRIs through its serotonin transporter inhibition, its additional receptor activities place it in its own distinct class 2, 5.
Dosing Recommendations
Initial Dosing
Start with 10 mg once daily 1. This can be taken:
- At any time of day
- With or without food
- No titration needed to reach starting dose
Dose Adjustments
After initiating treatment 1:
- Increase to 20 mg/day as tolerated for optimal efficacy
- Consider 5 mg/day for patients who cannot tolerate higher doses
- Maximum dose: 20 mg/day in most patients
Important caveat: In known CYP2D6 poor metabolizers, the maximum recommended dose is 10 mg/day 1.
Timing of Dose Escalation
Evidence from flexible-dose studies shows that nearly half of patients (48%) had their dose increased to 20 mg/day after just 1 week, and ultimately 64.3% of patients received 20 mg/day as their final maintenance dose 6. The 20 mg dose demonstrates significantly greater efficacy than 10 mg (difference of -1.03 points on MADRS; P < .05) with a similar tolerability profile 6.
When Used After SSRI/SNRI Failure
In patients switching from failed SSRI/SNRI treatment, a more aggressive dosing strategy has been studied: escalate to 20 mg/day by day 8 (second week), with treatment effectiveness assessed at 8-12 weeks 7. This approach achieved remission in 32-55% of treatment-resistant patients without increased adverse events 7.
Clinical Considerations
Nausea is the most common adverse effect and is dose-related, typically occurring in the first 1-2 weeks of treatment 1. However, rapid dose escalation to 20 mg does not appear to intensify nausea 7.
Discontinuation: While Trintellix can be stopped abruptly, it is recommended that doses of 15 mg/day or 20 mg/day be reduced to 10 mg/day for one week before full discontinuation to minimize discontinuation symptoms 1.